Application 021081
- Type
- NDA
- Sponsor
- SANOFI AVENTIS US
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LANTUS | INSULIN GLARGINE RECOMBINANT | INJECTABLE;INJECTION | 100 UNITS/ML | Yes | Yes |
| 002 | LANTUS SOLOSTAR | INSULIN GLARGINE RECOMBINANT | INJECTABLE;INJECTION | 300 UNITS/3ML (100 UNITS/ML) | Yes | Yes |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021081-001 | LANTUS | 100 UNITS/ML | INJECTABLE / INJECTION | RLD, RS | 2000-04-20 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | LANTUS SOLOSTAR | 300 UNITS/3ML (100 UNITS/ML) | INJECTABLE / INJECTION | RLD, RS | 2007-04-27 | 74a2ff9319b5… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021081-001 | LANTUS | 100 UNITS/ML | INJECTABLE / INJECTION | RLD, RS | 2000-04-20 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021081-002 | LANTUS SOLOSTAR | 300 UNITS/3ML (100 UNITS/ML) | INJECTABLE / INJECTION | RLD, RS | 2007-04-27 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021081-001 | LANTUS | 100 UNITS/ML | INJECTABLE / INJECTION | RLD, RS | 2000-04-20 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021081-002 | LANTUS SOLOSTAR | 300 UNITS/3ML (100 UNITS/ML) | INJECTABLE / INJECTION | RLD, RS | 2007-04-27 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021081-001 | LANTUS | 100 UNITS/ML | INJECTABLE / INJECTION | RLD, RS | 2000-04-20 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021081-002 | LANTUS SOLOSTAR | 300 UNITS/3ML (100 UNITS/ML) | INJECTABLE / INJECTION | RLD, RS | 2007-04-27 | ea99ee380514… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021081-001 | 7713930 | 2023-06-13 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021081-001 | 7476652 | 2023-07-23 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021081-001 | 7713930*PED | 2023-12-13 | Pediatric extension | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021081-001 | 7476652*PED | 2024-01-23 | Pediatric extension | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021081-001 | 7918833 | 2027-09-23 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021081-001 | 7918833*PED | 2028-03-23 | Pediatric extension | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 8603044 | 2024-03-02 | Drug product | 2014-01-06 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9233211 | 2024-03-02 | Drug product | 2016-01-13 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9408979 | 2024-03-02 | Drug product | 2016-09-15 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9526844 | 2024-03-02 | Drug product | 2016-12-27 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9604008 | 2024-03-02 | Drug product | 2017-03-28 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9610409 | 2024-03-02 | Drug product | 2017-04-04 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9775954 | 2024-03-02 | Drug product | 2017-10-03 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9827379 | 2024-03-02 | U-2146 | Drug product | 2017-11-28 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 8556864 | 2024-03-03 | Drug product | 2013-11-06 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9011391 | 2024-03-26 | U-1832 | 2015-05-01 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 8992486 | 2024-06-05 | Drug product | 2015-04-09 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9604009 | 2024-08-16 | Drug product | 2017-03-28 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9533105 | 2024-08-17 | Drug product | 2017-01-03 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9623189 | 2024-08-19 | Drug product | 2017-04-18 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9561331 | 2024-08-28 | Drug product | 2017-02-07 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 8512297 | 2024-09-15 | Drug product | 2013-08-21 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 8679069 | 2025-04-12 | Drug product | 2014-03-25 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021081-002 | 9717852 | 2033-04-08 | Drug product | 2018-07-11 | 74a2ff9319b5… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021081-001 | 7713930 | 2023-06-13 | Drug product | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021081-001 | 7476652 | 2023-07-23 | Drug product | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021081-001 | 7713930*PED | 2023-12-13 | Pediatric extension | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021081-001 | 7476652*PED | 2024-01-23 | Pediatric extension | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021081-001 | 7918833 | 2027-09-23 | Drug product | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021081-001 | 7918833*PED | 2028-03-23 | Pediatric extension | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021081-002 | 8603044 | 2024-03-02 | Drug product | 2014-01-06 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021081-002 | 9233211 | 2024-03-02 | Drug product | 2016-01-13 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021081-002 | 9408979 | 2024-03-02 | Drug product | 2016-09-15 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021081-002 | 9526844 | 2024-03-02 | Drug product | 2016-12-27 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021081-002 | 9604008 | 2024-03-02 | Drug product | 2017-03-28 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021081-002 | 9610409 | 2024-03-02 | Drug product | 2017-04-04 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021081-002 | 9775954 | 2024-03-02 | Drug product | 2017-10-03 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021081-002 | 9827379 | 2024-03-02 | U-2146 | Drug product | 2017-11-28 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021081-002 | 8556864 | 2024-03-03 | Drug product | 2013-11-06 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021081-002 | 9011391 | 2024-03-26 | U-1832 | 2015-05-01 | 3f01610625f2… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lantus Solostar | INSULIN GLARGINE | sanofi-aventis U.S. LLC | d5e07a0c-7e14-4756-9152-9fea485d654a | 2025-06-02 | Warnings, Adverse reactions | 0088-2219 0088-2220 |
| Insulin Glargine Solostar | INSULIN GLARGINE | A-S Medication Solutions | 9835904f-64f5-42b3-9ac9-89e4aaa5182a | 2023-11-01 | Warnings, Adverse reactions | 50090-6178 |
| LANTUS SOLOSTAR | INSULIN GLARGINE | A-S Medication Solutions | 3a97c40f-0c83-42d7-a8ee-484b208db4e3 | 2023-07-22 | Warnings, Adverse reactions | 50090-4068 |
| Lantus Solostar | INSULIN GLARGINE | A-S Medication Solutions | 632d9f68-f184-43d5-b184-a3af23f12ad9 | 2023-06-06 | Warnings, Adverse reactions | 50090-1398 |
| Lantus | INSULIN GLARGINE | A-S Medication Solutions | ae27bb66-5dbe-4f01-a89e-f4fa7cb09c99 | 2023-02-04 | Warnings, Adverse reactions | 50090-0876 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0088-2219 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-2219 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-2219 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-2219 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-2219 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-2219 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-2219 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-2219 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-2219 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-2220 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-2220 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-2220 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-2220 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-2220 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-2220 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-2220 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-2220 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-2220 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-5020 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-5020 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-5020 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-5020 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-5020 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-5020 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-5020 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-5020 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-5020 | Lantus Solostar | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-5021 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-5021 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-5021 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-5021 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-5021 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-5021 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-5021 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0088-5021 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | BLA | Current |
| 0088-5021 | Lantus | insulin glargine | sanofi-aventis U.S. LLC | NDA | Current |
| 0955-1728 | Insulin Glargine Solostar | insulin glargine | Winthrop U.S. | BLA | Current |
| 0955-1728 | Insulin Glargine Solostar | insulin glargine | Winthrop U.S. | BLA | Current |
| 0955-1729 | Insulin Glargine | insulin glargine | Winthrop U.S. | BLA | Current |
| 0955-1729 | Insulin Glargine | insulin glargine | Winthrop U.S. | BLA | Current |
| 12854-432 | Insulin Glargine Solostar | insulin glargine | Sanofi-Aventis Deutschland GmbH | BLA | Current |
| 12854-433 | Insulin Glargine | insulin glargine | Sanofi-Aventis Deutschland GmbH | BLA | Current |
| 50090-0876 | Lantus | insulin glargine | A-S Medication Solutions | NDA | Current |
| 50090-0876 | Lantus | insulin glargine | A-S Medication Solutions | BLA | Current |
| 50090-1398 | Lantus Solostar | insulin glargine | A-S Medication Solutions | BLA | Current |
| 50090-1398 | Lantus Solostar | insulin glargine | A-S Medication Solutions | NDA | Current |
| 50090-4068 | Lantus Solostar | insulin glargine | A-S Medication Solutions | BLA | Current |
| 50090-6178 | Insulin Glargine Solostar | insulin glargine | A-S Medication Solutions | BLA | Current |
| 50090-6184 | Insulin Glargine | insulin glargine | A-S Medication Solutions | BLA | Current |
| 55045-3685 | Lantus | insulin glargine | Dispensing Solutions, Inc. | NDA | Current |
| 64725-2220 | Lantus | insulin glargine | TYA Pharmaceuticals | NDA | Current |
| 70518-1390 | Lantus Solostar | insulin glargine | REMEDYREPACK INC. | NDA | Current |
| 70518-1390 | Lantus Solostar | insulin glargine | REMEDYREPACK INC. | BLA | Current |
| 70518-1865 | Lantus | insulin glargine | REMEDYREPACK INC. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 74674 | SUPPL | 2023-06-30 |
| 74673 | SUPPL | 2023-06-30 |
| 74672 | SUPPL | 2023-06-30 |
| 74671 | SUPPL | 2023-06-30 |
| 71258 | SUPPL | 2022-06-08 |
| 71252 | SUPPL | 2022-06-08 |
| 62378 | APPL | 2020-03-31 |
| 60960 | SUPPL | 2020-03-23 |
| 60959 | SUPPL | 2020-03-23 |
| 60909 | SUPPL | 2020-03-23 |
| 60908 | SUPPL | 2020-03-23 |
| 58646 | SUPPL | 2020-03-23 |
| 58638 | SUPPL | 2020-03-23 |
| 57207 | SUPPL | 2020-03-23 |
| 56817 | SUPPL | 2020-03-23 |
| 56597 | SUPPL | 2020-03-23 |
| 41938 | SUPPL | 2020-03-23 |
| 41937 | SUPPL | 2020-03-23 |
| 41936 | ORIG | 2020-03-23 |
| 36040 | SUPPL | 2020-03-23 |
| 36039 | SUPPL | 2020-03-23 |
| 36038 | SUPPL | 2020-03-23 |
| 36037 | SUPPL | 2020-03-23 |
| 36036 | SUPPL | 2020-03-23 |
| 36035 | SUPPL | 2020-03-23 |
| 36034 | ORIG | 2020-03-23 |
| 26679 | SUPPL | 2020-03-23 |
| 26678 | SUPPL | 2020-03-23 |
| 26677 | SUPPL | 2020-03-23 |
| 26676 | SUPPL | 2020-03-23 |
| 26675 | SUPPL | 2020-03-23 |
| 26674 | SUPPL | 2020-03-23 |
| 26673 | SUPPL | 2020-03-23 |
| 26672 | SUPPL | 2020-03-23 |
| 26671 | ORIG | 2020-03-23 |
| 23624 | ORIG | 2020-03-23 |
| 21426 | SUPPL | 2020-03-23 |
| 14314 | SUPPL | 2020-03-23 |
| 14313 | SUPPL | 2020-03-23 |
| 14312 | SUPPL | 2020-03-23 |
| 14311 | SUPPL | 2020-03-23 |
| 4241 | SUPPL | 2020-03-23 |
| 4240 | SUPPL | 2020-03-23 |